$POAI
Predictive Oncology Inc.

2018 Q2 Form 10-Q Financial Statement

#000117184318006072 Filed on August 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q4 2017 Q2
Revenue $358.6K $220.0K $106.8K
YoY Change 235.69% 57.14% 25.05%
Cost Of Revenue $109.0K $60.00K $22.01K
YoY Change 395.09% 100.0% -40.13%
Gross Profit $249.6K $160.0K $84.81K
YoY Change 194.32% 45.45% 74.31%
Gross Profit Margin 69.61% 72.73% 79.4%
Selling, General & Admin $1.284M $500.0K $2.446M
YoY Change -47.52% -18.03% 3.42%
% of Gross Profit 514.23% 312.5% 2884.0%
Research & Development $69.99K
YoY Change -30.18%
% of Gross Profit 82.52%
Depreciation & Amortization $18.83K $20.00K $14.52K
YoY Change 29.66% 0.0% -24.43%
% of Gross Profit 7.54% 12.5% 17.12%
Operating Expenses $1.284M $1.340M $2.516M
YoY Change -48.98% 59.52% 2.05%
Operating Profit -$1.413M -$1.180M -$2.431M
YoY Change -41.88% 61.64% 0.6%
Interest Expense -$960.0K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $50.00K
YoY Change
Pretax Income -$2.370M -$1.130M -$2.540M
YoY Change -6.69% 54.79% -0.78%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.373M -$1.130M -$2.540M
YoY Change -6.56% 54.79% -0.78%
Net Earnings / Revenue -661.88% -513.64% -2377.79%
Basic Earnings Per Share -$0.20
Diluted Earnings Per Share -$0.20 -$1.712M -$4.164M
COMMON SHARES
Basic Shares Outstanding 11.88M 6.168M
Diluted Shares Outstanding 11.88M

Balance Sheet

Concept 2018 Q2 2017 Q4 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M $1.010M $3.850M
YoY Change -74.03% -53.02% 79.91%
Cash & Equivalents $1.004M $766.2K $1.160M
Short-Term Investments $0.00 $240.0K $2.690M
Other Short-Term Assets $280.0K $290.0K $190.0K
YoY Change 47.37% 93.33% -13.64%
Inventory $244.7K $265.0K $242.2K
Prepaid Expenses
Receivables $315.3K $137.5K $45.00K
Other Receivables $160.0K $670.0K $0.00
Total Short-Term Assets $2.007M $2.371M $4.329M
YoY Change -53.63% -9.09% 61.7%
LONG-TERM ASSETS
Property, Plant & Equipment $184.4K $87.72K $109.9K
YoY Change 67.73% -13.58% -9.5%
Goodwill
YoY Change
Intangibles $115.1K $95.36K $93.31K
YoY Change 23.4% -2.57% -2.94%
Long-Term Investments $581.7K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.994M $1.253M $203.2K
YoY Change 881.03% 528.54% -6.6%
TOTAL ASSETS
Total Short-Term Assets $2.007M $2.371M $4.329M
Total Long-Term Assets $1.994M $1.253M $203.2K
Total Assets $4.001M $3.624M $4.532M
YoY Change -11.72% 29.09% 56.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $165.6K $140.5K $57.43K
YoY Change 188.35% -36.19% -92.35%
Accrued Expenses $455.3K $785.2K $1.184M
YoY Change -61.53% -41.67% 48.16%
Deferred Revenue $18.34K $6.663K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $640.0K $932.3K $1.255M
YoY Change -49.01% -40.77% -19.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $80.00K
YoY Change -100.0% -85.71%
Total Long-Term Liabilities $0.00 $0.00 $80.00K
YoY Change -100.0% -100.0% -85.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $640.0K $932.3K $1.255M
Total Long-Term Liabilities $0.00 $0.00 $80.00K
Total Liabilities $639.3K $932.3K $1.333M
YoY Change -52.03% -50.51% -36.83%
SHAREHOLDERS EQUITY
Retained Earnings -$58.90M -$53.02M -$50.90M
YoY Change 15.71% 12.77% 12.54%
Common Stock $120.9K $69.43K $61.89K
YoY Change 95.32% 52.12% -92.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.362M $2.692M $3.199M
YoY Change
Total Liabilities & Shareholders Equity $4.001M $3.624M $4.532M
YoY Change -11.72% 29.09% 56.56%

Cashflow Statement

Concept 2018 Q2 2017 Q4 2017 Q2
OPERATING ACTIVITIES
Net Income -$2.373M -$1.130M -$2.540M
YoY Change -6.56% 54.79% -0.78%
Depreciation, Depletion And Amortization $18.83K $20.00K $14.52K
YoY Change 29.66% 0.0% -24.43%
Cash From Operating Activities -$1.420M -$1.320M -$910.0K
YoY Change 56.04% 94.12% -23.53%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$10.00K -$10.00K
YoY Change 900.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $30.00K $0.00
YoY Change -84.21% -100.0%
Cash From Investing Activities -$110.0K $30.00K -$10.00K
YoY Change 1000.0% -83.33% -104.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 280.0K 1.300M 0.000
YoY Change -19.75%
NET CHANGE
Cash From Operating Activities -1.420M -1.320M -910.0K
Cash From Investing Activities -110.0K 30.00K -10.00K
Cash From Financing Activities 280.0K 1.300M 0.000
Net Change In Cash -1.250M 10.00K -920.0K
YoY Change 35.87% -99.11% -2.13%
FREE CASH FLOW
Cash From Operating Activities -$1.420M -$1.320M -$910.0K
Capital Expenditures -$100.0K -$10.00K -$10.00K
Free Cash Flow -$1.320M -$1.310M -$900.0K
YoY Change 46.67% 95.52% -24.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 aipt Class Of Warrant Or Right Number Of Warrants Vested And Exercisable
ClassOfWarrantOrRightNumberOfWarrantsVestedAndExercisable
2556382
aipt Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
aipt Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
aipt Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
216000
aipt Maintenance Plan Service Requirement Period Subsequent To One Year Anniversary Of Invoice
MaintenancePlanServiceRequirementPeriodSubsequentToOneYearAnniversaryOfInvoice
P1Y
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2902
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5790
CY2018Q2 us-gaap Assets
Assets
4001034
CY2018Q2 aipt Operating And Nonoperating Expense Total
OperatingAndNonoperatingExpenseTotal
1662518
CY2017Q2 aipt Operating And Nonoperating Expense Total
OperatingAndNonoperatingExpenseTotal
2628482
aipt Operating And Nonoperating Expense Total
OperatingAndNonoperatingExpenseTotal
3716789
aipt Operating And Nonoperating Expense Total
OperatingAndNonoperatingExpenseTotal
4108502
aipt Proceeds From Redemption Of Certificates Of Deposits
ProceedsFromRedemptionOfCertificatesOfDeposits
244971
aipt Proceeds From Redemption Of Certificates Of Deposits
ProceedsFromRedemptionOfCertificatesOfDeposits
CY2017 aipt Reverse Shares Issued For Escrow Under Termination Of Agreement Value
ReverseSharesIssuedForEscrowUnderTerminationOfAgreementValue
4000
aipt Standard Product Warranty Term
StandardProductWarrantyTerm
P1Y
CY2018Q2 aipt Valuation Allowance Percentage
ValuationAllowancePercentage
1
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
165588
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
140462
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
315327
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
137499
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
455326
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
785215
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
307091
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
273770
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62138569
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57380256
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2131821
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
460368
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
460368
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18276
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4070
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7741
CY2017Q4 us-gaap Assets
Assets
3624254
CY2018Q2 us-gaap Assets Current
AssetsCurrent
2007244
CY2017Q4 us-gaap Assets Current
AssetsCurrent
2371182
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
1837
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1004269
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
766189
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1764090
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1159849
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
238080
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-604241
CY2018Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
794125
CY2018Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
CY2017Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
244971
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2556382
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12089446
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6943283
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
120893
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
69432
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2373410
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2543670
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4133432
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3885517
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Credit Risk </div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> financial institution. The Company has a credit risk concentration because of depositing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$794,125</div> of funds in excess of insurance limits in a single bank.</div></div></div></div>
CY2018Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18342
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6663
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
6479
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108970
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22010
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
226314
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
59003
us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
5685000
CY2018Q2 us-gaap Depreciation
Depreciation
18825
us-gaap Depreciation
Depreciation
33321
CY2017Q2 us-gaap Depreciation
Depreciation
14519
us-gaap Depreciation
Depreciation
30204
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41062
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35995
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
997772
CY2018Q2 us-gaap Equity Method Investments
EquityMethodInvestments
581742
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
CY2017Q2 us-gaap Gross Profit
GrossProfit
84812
us-gaap Gross Profit
GrossProfit
543865
us-gaap Gross Profit
GrossProfit
222985
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-960508
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-960508
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
729528
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2214705
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1945670
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3346777
CY2018Q2 us-gaap Gross Profit
GrossProfit
249616
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25126
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-162685
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
177828
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6085
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-329889
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-394767
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11679
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6159
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20385
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30004
us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
42524
us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14490
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
39892
CY2018Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2017Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
115139
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
95356
CY2018Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
31782
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
62932
CY2018Q2 us-gaap Inventory Net
InventoryNet
244660
CY2017Q4 us-gaap Inventory Net
InventoryNet
265045
CY2018Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
168735
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
141028
CY2018Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
44143
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
61085
CY2018Q2 us-gaap Liabilities
Liabilities
639256
CY2017Q4 us-gaap Liabilities
Liabilities
932340
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4001034
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3624254
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3300678
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3814938
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
44933
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2348375
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3107531
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2070804
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4133432
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3885517
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2373410
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2543670
CY2018Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
167512
CY2017Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
667512
CY2018Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1112524
CY2017Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1070000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2018Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
378906
CY2017Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
182507
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
666496
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
383001
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1501
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
27524
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1229
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
129990
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38637
us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
2593174
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
275476
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
289966
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2959509
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3814938
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
284665
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
341169
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
491476
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
361486
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
184385
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87716
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58898477
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54765045
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
358586
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
106822
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
770179
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
281988
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
554084
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
231270
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1104623
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
378724
us-gaap Share Based Compensation
ShareBasedCompensation
460368
us-gaap Share Based Compensation
ShareBasedCompensation
2131821
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3120255
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2154442
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.05
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
1900000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y146D
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3421188
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2755087
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
923682
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2691914
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
3361778
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
35840380
us-gaap Transfer To Investments
TransferToInvestments
1542250
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6308554
us-gaap Transfer To Investments
TransferToInvestments
CY2018Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Accounting Policies and Estimates</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The presentation of financial statements is in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div>
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11878490
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6167689
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11632221
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11878490
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6167689
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11632221
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6308554

Files In Submission

Name View Source Status
0001171843-18-006072-index-headers.html Edgar Link pending
0001171843-18-006072-index.html Edgar Link pending
0001171843-18-006072.txt Edgar Link pending
0001171843-18-006072-xbrl.zip Edgar Link pending
aipt-20180630.xml Edgar Link completed
aipt-20180630.xsd Edgar Link pending
aipt-20180630_cal.xml Edgar Link unprocessable
aipt-20180630_def.xml Edgar Link unprocessable
aipt-20180630_lab.xml Edgar Link unprocessable
aipt-20180630_pre.xml Edgar Link unprocessable
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_081418p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending